YLabs, in partnership with women’s healthcare company, Organon, developed this first-of-its-kind strategic framework on how funders can assess, anticipate, and respond to the gendered impacts of climate change on sexual and reproductive health and rights (SRHR) investments.

This resource was developed through a comprehensive desk review of 48 peer-reviewed articles and white papers to assess current evidence about the impacts of climate change on SRHR in low and middle income countries (LMIC). A call for case studies from grassroots SRHR organizations (n=16), as well as expert interviews (n=21), were conducted to understand SRHR challenges faced by women and girls because of climate change, and examples of adaptation strategies being used at the community level.

This framework was authored by: 

Dr. Adedamola Adebayo
Senior Technical Specialist, YLabs 

Theodora Gibbs-Plessl
Senior Climate Advisor, YLabs 

Nicole Ippoliti
Technical Director, YLabs

Editorial support was provided by: Rebecca Hope, CEO, YLabs

This work was guided by a global advisory committee of climate and SRHR experts and funding partners including:

Lorena Aguilar

Executive Director Kaschak Institute for Social Justice for Women and Girls

Sono Aibe

Global Health and Philanthropy Consultant

Byron Austin

Head of Corporate Responsibility & ESG Management, Organon

Meg Brown

Postdoctoral Fellow, Pathfinder International

Dr. Deepika Devadas

Chief of Staff to co-CEO, Grand Challenges Canada

Khusbu Poudel

Program Coordinator, Ipas Nepal

Based in Rwanda and the USA, YLabs is a youth-driven design and research organization that designs products and services with youth that amplify their power, agency, and opportunity. Founded in 2016 at the Harvard Innovation Lab, its multi-disciplinary team has worked with youth across 17 countries to co-create innovations in five key focus areas: HIV/AIDS, sexual and reproductive health, mental health, economic inclusion, and climate resilience.

Organon is a global healthcare company formed through a spin-off from Merck & Co., Inc., Rahway, New Jersey, United States (MSD outside of the United States and Canada), with the vision to create a better and healthier every day for every woman. Organon seeks to deliver innovation, improve access, and expand choice to help address the unmet medical needs of women, and ultimately improve their lives.